130 related articles for article (PubMed ID: 20664352)
1. Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse.
Reimer C; Bytzer P
Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1182-8. PubMed ID: 20664352
[TBL] [Abstract][Full Text] [Related]
2. A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia.
Rabeneck L; Souchek J; Wristers K; Menke T; Ambriz E; Huang I; Wray N
Am J Gastroenterol; 2002 Dec; 97(12):3045-51. PubMed ID: 12492188
[TBL] [Abstract][Full Text] [Related]
3. Empiric treatment with high and standard dose of omeprazole in general practice: two-week randomized placebo-controlled trial and 12-month follow-up of health-care consumption.
Meineche-Schmidt V
Am J Gastroenterol; 2004 Jun; 99(6):1050-8. PubMed ID: 15180724
[TBL] [Abstract][Full Text] [Related]
4. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A
Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806
[TBL] [Abstract][Full Text] [Related]
5. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
Raghunath AS; Hungin AP; Mason J; Jackson W
Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981
[TBL] [Abstract][Full Text] [Related]
6. Classification of dyspepsia and response to treatment with proton-pump inhibitors.
Meineche-Schmidt V
Aliment Pharmacol Ther; 2004 Nov; 20(10):1171-9. PubMed ID: 15569120
[TBL] [Abstract][Full Text] [Related]
7. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
8. Impact of dialysis on gastroesophageal reflux, dyspepsia, and proton pump inhibitor treatment in patients with chronic renal failure.
Strid H; Fjell A; Simrén M; Björnsson ES
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):137-42. PubMed ID: 19212202
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.
Veldhuyzen van Zanten SJ; Chiba N; Armstrong D; Barkun A; Thomson A; Smyth S; Escobedo S; Lee J; Sinclair P
Am J Gastroenterol; 2005 Jul; 100(7):1477-88. PubMed ID: 15984968
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors for dyspepsia.
Vakil N
Dig Dis; 2008; 26(3):215-7. PubMed ID: 18463438
[TBL] [Abstract][Full Text] [Related]
11. Randomised clinical trial: identification of responders to short-term treatment with esomeprazole for dyspepsia in primary care - a randomised, placebo-controlled study.
Meineche-Schmidt V; Christensen E; Bytzer P
Aliment Pharmacol Ther; 2011 Jan; 33(1):41-9. PubMed ID: 21083590
[TBL] [Abstract][Full Text] [Related]
12. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
Peura DA; Kovacs TO; Metz DC; Siepman N; Pilmer BL; Talley NJ
Am J Med; 2004 Jun; 116(11):740-8. PubMed ID: 15144910
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial.
Jarbol DE; Kragstrup J; Stovring H; Havelund T; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 2006 Jun; 101(6):1200-8. PubMed ID: 16771937
[TBL] [Abstract][Full Text] [Related]
14. [Adverse events associated with long-term use of proton pump inhibitors].
Reimer C; Bytzer P
Ugeskr Laeger; 2012 Sep; 174(39):2289-93. PubMed ID: 23006222
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial: long-term use of proton pump inhibitors in primary care patients - a cross sectional analysis of 901 patients.
Reimer C; Bytzer P
Aliment Pharmacol Ther; 2009 Oct; 30(7):725-32. PubMed ID: 19604180
[TBL] [Abstract][Full Text] [Related]
16. It is difficult to discontinue PPI treatment in patients with GERD.
Bjornsson E
Am J Gastroenterol; 2011 Feb; 106(2):367-8; author reply 368. PubMed ID: 21301460
[No Abstract] [Full Text] [Related]
17. A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome.
Lewin van den Broek NT; Numans ME; Buskens E; Verheij TJ; de Wit NJ; Smout AJ
Br J Gen Pract; 2001 Aug; 51(469):619-24. PubMed ID: 11510389
[TBL] [Abstract][Full Text] [Related]
18. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
Inadomi JM; McIntyre L; Bernard L; Fendrick AM
Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
[TBL] [Abstract][Full Text] [Related]
20. Which dyspepsia patients will benefit from omeprazole treatment? Analysis of a Danish multicenter trial.
Meineche-Schmidt V; Christensen E
Am J Gastroenterol; 2000 Oct; 95(10):2777-83. PubMed ID: 11051347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
